Kunming Pharmaceutical Corp.  

(Public, SHA:600422)   Watch this stock  
Find more results for 600422
Mar 27 - Close
SHA data delayed by 1 mins - Disclaimer
Currency in CNY
Range     -
52 week 19.80 - 29.83
Open     -
Vol. 0.00
Mkt cap 9.90B
P/E 33.67
EPS 0.86
Shares 341.13M
Apr 2, 2015
Kunming Pharmaceutical Corp Annual Shareholders Meeting - 9:30AM GMT+8 - Add to calendar

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 7.41% 7.47%
Operating margin 7.83% 8.24%
EBITD margin - 9.24%
Return on average assets 12.15% 10.41%
Return on average equity 18.97% 15.87%
Employees 3,292 -
CDP Score - -


No. 166 Keyi Road, High-tech Development Zone
+86-871-68319868 (Phone)
+86-871-68311968 (Fax)

Website links


Kunming Pharmaceutical Corp. is a China-based company principally engaged in manufacture, wholesaling and retailing of pharmaceuticals. The Company provides natural herbal medicines and chemical compound drugs, including drugs for central nervous systems, drugs for cardio and cerebral vascular diseases, anti-parasite drugs, antimicrobial drugs, anti-gout drugs, hormones and endocrine regulation drugs, drugs for hemorrhoids and anti-inflammatory drugs, among others. The Company also involves in pharmaceutical purchasing and distribution, as well as health supplements manufacturing. It distributes its products in domestic and overseas markets.

Officers and directors

Qin He Chairman of the Board
Age: 53
Pingdong Yuan President
Age: 44
Jiahong Lin Vice Chairman of the Board
Age: 44
Huijiang Liu Vice Chairman of the Board
Age: 58
Shaoquan Wang Chief Financial Officer
Age: 45
Chaoneng Xu Vice President, Secretary of the Board
Age: 49
Shaoyu Dong Vice President
Age: 56
Zhongzhan Lin Vice President
Age: 44
Peng Liu Vice President
Age: 49
Rong Pei Director
Age: 42